HOME › DRUGS › SATAVAPTAN
ACTIVE SUBSTANCE / INN

SATAVAPTAN

Brand name(s): Aquilda
EMA LISTED
APPLICATION WITHDRAWN
Hyponatremia
ACTIVE SUBSTANCE
Satavaptan
REGULATORS
EMA
SPONSORS / MAH
Sanofi-Aventis
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AquildaSanofi-AventisApplication withdrawnHyponatremia

FULL INTELLIGENCE ON SATAVAPTAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →